Please login to the form below

Not currently logged in
Email:
Password:

Problems at home can prevent children taking asthma drugs

Busy parents and financial problems could lead to poorer medicine adherence

Children's adherence to asthma medication is negatively affected by “parental problems and a chaotic home environment”, according to a new study presented at the European Respiratory Society's annual congress in Vienna, Austria.

The report claims that issues at home, including busy parents and financial problems, can lead to children not taking their medicine, causing asthma symptoms to worsen.

Researchers in the Netherlands electronically measured how well children took their maintenance medication as part of an ongoing project to assess influences on adherence in asthma, with non-adherence already understood to be a common problem.

They followed this by interviewing the parents of 20 children, split between those with the highest levels of adherence and those with the lowest, to try and understand what was preventing some children following their treatment plan.

Although all parents said they intended to strictly follow the agreed treatment plan, a variety of lifestyle factors meant such intentions were not followed through, with some parents even giving their children full responsibility to take their medication as prescribed, with the lack of parental support resulting in low adherence.

The study's results were supported by David Supple, the parent of a child with asthma.

Speaking about his own experience, he said: “It can be chaotic having four children, and when we have given our son Alex responsibility over his medication to control his asthma, we have found his adherence slip away.”

The study's lead author Professor Paul Brand said the results should influence the way doctors treat children with asthma.

“It is crucial that healthcare professionals treating children with asthma carefully assess what these potential barriers could be so that appropriate interventions can be put in place to help correct the problems.”

Adherence is becoming one of the biggest challenges for both the pharma industry and healthcare systems, with patients potentially facing damaging consequences if they do not stick to a treatment plan.

This has led to calls from several major European healthcare organisations, including the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Patients' Forum (EPF), for action across the EU to improve adherence.

There has also been action in the US from the National Consumers League, which launched an awareness campaign, with a free text message medication reminder service, last year.

4th September 2012

From: Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics